These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36430352)

  • 1. Overexpression of Ubiquitin-Conjugating Enzyme E2C Is Associated with Worsened Prognosis in Prostate Cancer.
    Wu X; Long X; Ma C; Cheuk YC; Hu M; Hu J; Jiang H
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of UBE2C as hub gene in driving prostate cancer by integrated bioinformatics analysis.
    Wang Y; Wang J; Tang Q; Ren G
    PLoS One; 2021; 16(2):e0247827. PubMed ID: 33630978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer effect of icaritin on prostate cancer via regulating miR-381-3p and its target gene UBE2C.
    Hu J; Wu X; Yang C; Rashid K; Ma C; Hu M; Ding Q; Jiang H
    Cancer Med; 2019 Dec; 8(18):7833-7845. PubMed ID: 31646760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer.
    Lee CH; Ku JY; Ha JM; Bae SS; Lee JZ; Kim CS; Ha HK
    Prostate; 2017 Jan; 77(1):60-71. PubMed ID: 27550197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of ubiquitin-conjugating enzyme E2C in proliferation and invasion of prostate carcinoma cells.
    Shuliang S; Lei C; Guangwu J; Changjie L
    Oncol Res; 2013; 21(3):121-7. PubMed ID: 24512726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-Cancer Analyses of the Tumor Microenvironment Reveal That Ubiquitin-Conjugating Enzyme E2C Might Be a Potential Immunotherapy Target.
    Huang GZ; Chen ZQ; Wu J; Shao TR; Zou C; Ai YL; Lv XZ
    J Immunol Res; 2021; 2021():9250207. PubMed ID: 34950739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of ubiquitin-conjugating enzyme E2C and KAI1 in ovarian carcinoma and their clinical significance.
    Gong Y; Wang D; Lin L; Dai J; Yu L
    Medicine (Baltimore); 2019 Nov; 98(46):e17896. PubMed ID: 31725636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The correlation between the expression of ubiquitin-conjugating enzyme 2C and prostate cancer prognosis.
    Kim JH; Lee KW; Yang HJ; Park JJ; Lee CH; Jeon YS; Yun JH; Park S; Song SJ; Kim YH; Lee JH; Moon A; Song YS
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6351-6360. PubMed ID: 36752909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin inhibits prostate cancer by upregulating miR-483-3p and inhibiting UBE2C.
    Li W; Wang F; Wang X; Xu W; Liu F; Hu R; Li S
    J Biochem Mol Toxicol; 2024 Feb; 38(2):e23645. PubMed ID: 38348716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression.
    Ieta K; Ojima E; Tanaka F; Nakamura Y; Haraguchi N; Mimori K; Inoue H; Kuwano H; Mori M
    Int J Cancer; 2007 Jul; 121(1):33-8. PubMed ID: 17354233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of UBE2C in esophageal squamous cell carcinoma tissues and molecular analysis.
    Li R; Pang XF; Huang ZG; Yang LH; Peng ZG; Ma J; He RQ
    BMC Cancer; 2021 Sep; 21(1):996. PubMed ID: 34488675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined elevation of AURKB and UBE2C predicts severe outcomes and therapy resistance in glioma.
    Alafate W; Zuo J; Deng Z; Guo X; Wu W; Zhang W; Xie W; Wang M; Wang J
    Pathol Res Pract; 2019 Oct; 215(10):152557. PubMed ID: 31353228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of UBE2C in lung adenocarcinoma based on database analysis and its clinical significance.
    Liu Y; Huang F; Chen H; Peng Q; Zhao C; Miao L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Sept 28; 45(9):1044-1052. PubMed ID: 33051417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UBE2C promotes the progression of head and neck squamous cell carcinoma.
    Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
    Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UBE2C is overexpressed in ESCC tissues and its abrogation attenuates the malignant phenotype of ESCC cell lines.
    Palumbo A; Da Costa NM; De Martino M; Sepe R; Pellecchia S; de Sousa VP; Nicolau Neto P; Kruel CD; Bergman A; Nasciutti LE; Fusco A; Pinto LF
    Oncotarget; 2016 Oct; 7(40):65876-65887. PubMed ID: 27588470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin-conjugating enzyme E2C (UBE2C) is a prognostic indicator for cholangiocarcinoma.
    Ong KH; Lai HY; Sun DP; Chen TJ; Huang SK; Tian YF; Chou CL; Shiue YL; Chan TC; Li CF; Kuo YH
    Eur J Med Res; 2023 Dec; 28(1):593. PubMed ID: 38102624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated Analysis Revealed Prognostic Factors for Prostate Cancer Patients.
    Che H; Liu Y; Zhang M; Meng J; Feng X; Zhou J; Liang C
    Med Sci Monit; 2019 Dec; 25():9991-10007. PubMed ID: 31876269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing ubiquitin-conjugating enzyme 2C inhibits proliferation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
    Wang X; Yin L; Yang L; Zheng Y; Liu S; Yang J; Cui H; Wang H
    FEBS J; 2019 Dec; 286(24):4889-4909. PubMed ID: 31715067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin-conjugating enzyme E2C: a potential cancer biomarker.
    Xie C; Powell C; Yao M; Wu J; Dong Q
    Int J Biochem Cell Biol; 2014 Feb; 47():113-7. PubMed ID: 24361302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of UBE2C in Brain Cancer Invasion and Dissemination.
    Domentean S; Paisana E; Cascão R; Faria CC
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.